Related Experiment Video

Updated: May 13, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

Novel Biomarkers for Cardio-renal Syndrome

Sul Ra Lee1, Kyung Hwan Jeong

  • 1Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.

Electrolyte & Blood Pressure : E & BP
|March 20, 2013
PubMed

Insights

Cardio-renal syndrome (CRS) involves heart and kidney dysfunction. Novel biomarkers show promise for early acute kidney injury (AKI) detection and predicting outcomes in CRS patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarker Research

Background:

  • Cardio-renal syndrome (CRS) is a critical condition where heart and kidney dysfunction are interconnected.
  • Acute kidney injury (AKI) significantly increases morbidity and mortality in CRS patients.
  • Current markers like serum creatinine lack sensitivity for early AKI detection.

Purpose of the Study:

  • To review novel renal and cardiac biomarkers for CRS.
  • To discuss the potential of these biomarkers in predicting AKI and patient prognosis.
  • To explore how biomarkers can improve clinical outcomes in CRS.

Main Methods:

  • Literature review of studies on renal and cardiac biomarkers in CRS.
  • Analysis of biomarker roles in AKI prediction and prognosis.
  • Discussion of established and emerging biomarkers, including natriuretic peptides.

Main Results:

  • Novel biomarkers are being explored for early AKI detection, surpassing serum creatinine.
  • Biomarker studies identify predictors for poor prognosis, including renal replacement therapy (RRT) and mortality.
  • Emerging cardiac biomarkers, beyond natriuretic peptides, may be crucial in managing CRS.

Conclusions:

  • Biomarkers hold potential for early AKI detection and risk stratification in CRS.
  • Identifying prognostic biomarkers can guide treatment and improve clinical outcomes.
  • Further research into novel renal and cardiac biomarkers is essential for advancing CRS management.

Keywords:
Acute kidney injuryBiomarkerCardio-renal syndromeHeart failure

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...